Informations sur le produit
ZL006 is a potential drug target that has been shown to inhibit the activity of GABA transaminase, an enzyme that breaks down the neurotransmitter γ-aminobutyric acid. It also inhibits neuronal death caused by ischemia reperfusion injury in rats and may have therapeutic effects on Parkinson's disease. ZL006 has a hydroxyl group at the para position, which is important for its pharmacological properties. It also has inhibitory properties against locomotor activity in rats and rotarod test performance in mice. ZL006 has been shown to be well absorbed orally and distributed throughout the body after intravenous administration, with a half-life of approximately 45 minutes.
Propriétés chimiques
Question d’ordre technique sur : 3D-GXB22602 ZL006
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages